Robust demand helps Lonza meet mid-term goal
Lonza has felt “no negative impact” from the economic crisis and demand from clients remains strong, which will enable the company to post average growth in the high teens until 2013.
China ramps up stem cell efforts just weeks after US research U-turn
Construction of a new stem cell research and processing plant began yesterday in China’s Eastern Jiangsu province as part of a joint project between the Chinese government and Shenzen Beike Biotechnology.
Hovione shows off Irish API plant
API maker Hovione’s manufacturing facility in Cork, Ireland was unveiled at an opening ceremony yesterday just two weeks after the previous owner, global drug giant Pfizer, formally handed over the keys.
Aoxing’s pain drug plant gets GMP OK
China Aoxing Pharmaceutical, a specialist developer of pain management drugs, has received GMP accreditation for the new tablet production and packaging plant it has set up in Shijiazhuang.
Polestar launches sensor for disposable reactors
Polestar Technologies has launched its iDOT single-use pH and dissolved oxygen sensor, which can be welded into the walls of disposable reactors to provide in situ process monitoring.
bioMerieux launches “groundbreaking” MFT medias
French diagnostics and microbiology firm bioMerieux claims its new range of indicator medias will help drugmakers cut testing times and reduce errors during GMP mandated sterility analysis.
MWV expands blister pack range with Shellpak-170
US contractor MeadWestvaco (MWV) claims the latest addition to its Shellpack range, the Shellpak-170, offers drugmakers more options for adherence promotion blister packaging.
PharmEng to make proposal under bankruptcy act
PharmEng has filed a notice of intent (NOI) to make a proposal under the Canadian Bankruptcy and Insolvency Act in an attempt to “regain the company's financial footing”.
US CMOs economy proof in the long term, says F&S
The US contract manufacturing sector is strong enough to bounce back from any short-term slow down caused by the credit crisis, according to a new report by Frost & Sullivan (F&S).
ASEAN GMP audit sharing a step to EU-like single market
The Association of Southeast Asia Nations’ (ASEAN) member states will recognise each others GMP certificates as part of a programme intended to raise standards and eliminate trade barriers.
Almac automates pre-trial validation with HP’s help
Almac claims it can bring drugs to trial faster using an automated approach to compliance that cuts the time taken to validate manufacturing processes by several months.
Cash-strapped PharmEng cuts back again
Troubled Canadian contract manufacturing firm PharmEng International, faced with a serious cash flow crisis, has announced the departure of chief financial officer Brian Fielding and two other senior executives.
Shire to close Owings Mills Adderall XR plant
Biopharmaceuticals firm Shire will cease manufacture at its plant in Owings Mills, Maryland, US with the loss of 260 jobs in the latest stage of its plan to wind up the in-house production of small molecule drugs.
FDA issues final guidance on ICH Q10
The FDA has provided a model for implementing the ICH Q10 quality control system in its final guidance, which is intended help manufacturers adapt processes throughout a product’s lifecycle.
Companies are maintaining their spending on quality control measures despite the challenging operating environment, according to Matthew Kopecky, product manager at Sparta Systems.